Khushbu J Patel, David Yang, John R Best, Colleen Chambers, Philip E Lee, Alexandre Henri-Bhargava, Clark R Funnell, Dean J Foti, Jacqueline A Pettersen, Howard H Feldman, Haakon B Nygaard, Ging-Yuek R Hsiung, Mari L DeMarco
INTRODUCTION: In the Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia (IMPACT-AD BC) study, we aimed to understand how Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarker testing-used in medical care-impacted medical decision-making (medical utility), personal decision-making (personal utility), and health system economics. METHODS: The study was designed as an observational, longitudinal cohort study. A total of 149 patients were enrolled between February 2019 and July 2021...
2024: Alzheimer's & Dementia: Translational Research & Clinical Interventions